The analysts at SunTrust Robinson Humphrey put together a big list stocks ideas that they feel will outperform into year-end 2019. That list includes these five health care stocks with sizable upside.
SmileDirectClub had an absolutely dismal initial public offering, but some analysts say they see very high upside, now that the quiet period has concluded.
DBV Technologies shares dipped on Monday after the firm announced an update from the FDA. Although it was a positive update for the company, this appears to be a case of “sell the news.”
Eli Lilly announced some good news for people suffering moderate to severe plaque psoriasis when it presented at the 5th Annual Maui Derm NP+PA Fall meeting.
That experiencing a decline in income might upset somebody is a no-brainer, but new research suggests that it might literally affect the brain in negative ways.
One analyst issued a fairly bullish report in response to Johnson & Johnson's announcement of a $10 million settlement with two Ohio counties ahead of an upcoming opioid trial.
Merck has just announced that the FDA has accepted a couple new drug applications for review, including for a treatment for Clostridium difficile infections in children.
Conformis shares shot up on Tuesday after the firm announced that it has entered into definitive agreements to sell and license to Stryker to develop, manufacture and supply PSI for use in connection with…
Five drugmakers are considering a proposal that would have them contribute to a trust established as part of the bankruptcy settlement by Purdue Pharmaceuticals and be released from liability in the hundreds of other…